← All companies

ABT

Abbott Laboratories

ABT NYSE Pharmaceutical Preparations EDGAR ↗

$107.12

+1.51 +1.43%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$81.97 – $137.49

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 28, 2026 8-K Results of operations (earnings release) Jul 16, 2026 10-Q Quarter ended 2026-03-31 Apr 29, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Apr 27, 2026 8-K Other events Apr 17, 2026 8-K Results of operations (earnings release) Apr 16, 2026 8-K Other events Mar 23, 2026 8-K Entered a material agreement; Took on a direct financial obligation Mar 9, 2026 8-K Entered a material agreement Feb 26, 2026 8-K Amended charter or bylaws Feb 20, 2026 10-K Fiscal year ended 2025-12-31 Feb 20, 2026 8-K Results of operations (earnings release) Jan 22, 2026 8-K Director or officer change; Amended charter or bylaws Dec 12, 2025 8-K Item 5.04 Nov 21, 2025 8-K Entered a material agreement; Regulation FD disclosure; Other events Nov 20, 2025 10-Q Quarter ended 2025-09-30 Oct 29, 2025 8-K Results of operations (earnings release) Oct 15, 2025 10-Q Quarter ended 2025-06-30 Jul 30, 2025 8-K Results of operations (earnings release) Jul 17, 2025 8-K Director or officer change May 1, 2025 10-Q Quarter ended 2025-03-31 Apr 30, 2025 8-K Shareholder vote results Apr 28, 2025 8-K Results of operations (earnings release) Apr 16, 2025 10-K Fiscal year ended 2024-12-31 Feb 21, 2025 8-K Results of operations (earnings release) Jan 22, 2025 8-K Director or officer change Nov 15, 2024 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release) Oct 16, 2024 10-Q Quarter ended 2024-06-30 Jul 31, 2024 8-K Results of operations (earnings release) Jul 18, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Director or officer change May 1, 2024 8-K Shareholder vote results Apr 29, 2024 8-K Results of operations (earnings release) Apr 17, 2024 10-K Fiscal year ended 2023-12-31 Feb 16, 2024 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Jan 29, 2024 8-K Results of operations (earnings release) Jan 24, 2024 10-Q Quarter ended 2023-09-30 Nov 1, 2023 8-K Results of operations (earnings release) Oct 18, 2023 8-K/A Shareholder vote results Sep 1, 2023